LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification
暂无分享,去创建一个
Junnian Zheng | Zhongwei Li | P. Hou | Minle Li | Sufang Chu | Tian-Yu Lin | Yuming Gu | Sen Meng | Junchao Bai | Pingfu Hou
[1] Likun Zhou,et al. LINC00460-miR-149-5p/miR-150-5p-Mutant p53 Feedback Loop Promotes Oxaliplatin Resistance in Colorectal Cancer , 2020, Molecular therapy. Nucleic acids.
[2] Yifan Lian,et al. Upregulation of lncRNA LINC00460 Facilitates GC Progression through Epigenetically Silencing CCNG2 by EZH2/LSD1 and Indicates Poor Outcomes , 2020, Molecular therapy. Nucleic acids.
[3] F. Lin,et al. lncRNA LINC00460 Silencing Represses EMT in Colon Cancer through Downregulation of ANXA2 via Upregulating miR-433-3p , 2019, Molecular therapy. Nucleic acids.
[4] J. Ji,et al. LINC00460 promotes hepatocellular carcinoma development through sponging miR-485-5p to up-regulate PAK1. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[5] Chunyan Zhang,et al. Linc00460 promotes osteosarcoma progression via miR-1224-5p/FADS1 axis. , 2019, Life sciences.
[6] Ming Yan,et al. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus , 2019, Journal of Experimental & Clinical Cancer Research.
[7] Bin Wang,et al. Long noncoding RNA LINC00460 aggravates invasion and metastasis by targeting miR-30a-3p/Rap1A in nasopharyngeal carcinoma , 2019, Human Cell.
[8] Y. Dong,et al. Downregulated LINC00460 inhibits cell proliferation and promotes cell apoptosis in prostate cancer. , 2019, European review for medical and pharmacological sciences.
[9] Yanli Wang,et al. Long non-coding RNA LINC00460 promotes epithelial ovarian cancer progression by regulating microRNA-338-3p. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[10] Peng Sun,et al. Long noncoding RNA LINC00460 targets miR-539/MMP-9 to promote meningioma progression and metastasis. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[11] Jun Song,et al. KIF4A facilitates cell proliferation via induction of p21-mediated cell cycle progression and promotes metastasis in colorectal cancer , 2018, Cell Death & Disease.
[12] Dan Sun,et al. Long non-coding RNA linc00460 promotes epithelial-mesenchymal transition and cell migration in lung cancer cells. , 2018, Cancer letters.
[13] Di Chen,et al. The LINC01138 drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinoma , 2018, Nature Communications.
[14] Shenglin Huang,et al. The LINC01138 drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinoma , 2018, Nature Communications.
[15] Y-H Zhang,et al. Effects of Linc00460 on cell migration and invasion through regulating epithelial-mesenchymal transition (EMT) in non-small cell lung cancer. , 2018, European review for medical and pharmacological sciences.
[16] Stefan Hüttelmaier,et al. Recognition of RNA N6-methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation , 2018, Nature Cell Biology.
[17] Xing Chen,et al. MeT-DB V2.0: elucidating context-specific functions of N6-methyl-adenosine methyltranscriptome , 2017, Nucleic Acids Res..
[18] Francine E. Garrett-Bakelman,et al. The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal and leukemia cells , 2017, Nature Medicine.
[19] R. Sadreyev,et al. IGF2 mRNA binding protein-2 is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1 , 2017, eLife.
[20] D. Glavač,et al. Long Noncoding RNAs as Biomarkers in Cancer , 2017, Disease markers.
[21] B. Erman,et al. Long noncoding RNA (lincRNA), a new paradigm in gene expression control , 2016, Functional & Integrative Genomics.
[22] K. Hall. Faculty Opinions recommendation of Chromosomes. A comprehensive Xist interactome reveals cohesin repulsion and an RNA-directed chromosome conformation. , 2017 .
[23] Z. Cai,et al. HOTTIP: a critical oncogenic long non-coding RNA in human cancers. , 2016, Molecular bioSystems.
[24] P. Ivanov,et al. The Long Non-coding RNA HIF1A-AS2 Facilitates the Maintenance of Mesenchymal Glioblastoma Stem-like Cells in Hypoxic Niches. , 2016, Cell reports.
[25] A. Jemal,et al. Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.
[26] R. Reeves. High mobility group (HMG) proteins: Modulators of chromatin structure and DNA repair in mammalian cells. , 2015, DNA repair.
[27] Maite Huarte. The emerging role of lncRNAs in cancer , 2015, Nature Medicine.
[28] Jeannie T. Lee,et al. Chromosomes. A comprehensive Xist interactome reveals cohesin repulsion and an RNA-directed chromosome conformation. , 2015, Science.
[29] G. Launoy,et al. Incidence and survival in late liver metastases of colorectal cancer , 2015, Journal of gastroenterology and hepatology.
[30] Junhui Ge,et al. Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus , 2014, Cell Research.
[31] J. Pelletier,et al. Suppression of the DHX9 Helicase Induces Premature Senescence in Human Diploid Fibroblasts in a p53-dependent Manner* , 2014, The Journal of Biological Chemistry.
[32] Hongtu Zheng,et al. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer. , 2014, International journal of clinical and experimental pathology.
[33] Xuetao Cao,et al. The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation , 2014, Science.
[34] Junhui Ge,et al. Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus , 2014, Cell Research.
[35] A. Fatica,et al. Long non-coding RNAs: new players in cell differentiation and development , 2013, Nature Reviews Genetics.
[36] Zhike Lu,et al. m6A-dependent regulation of messenger RNA stability , 2013, Nature.
[37] A. Bacolla,et al. DHX9 helicase is involved in preventing genomic instability induced by alternatively structured DNA in human cells , 2013, Nucleic acids research.
[38] J. Foekens,et al. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer , 2013, Genome research.
[39] P. Thibault,et al. A Host YB-1 Ribonucleoprotein Complex Is Hijacked by Hepatitis C Virus for the Control of NS3-Dependent Particle Production , 2013, Journal of Virology.
[40] E. Pennisi. Long noncoding RNAs may alter chromosome's 3D structure. , 2013, Science.
[41] B. Stefanovic,et al. A novel role of RNA helicase A in regulation of translation of type I collagen mRNAs. , 2012, RNA.
[42] S. Miyano,et al. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. , 2011, Cancer research.
[43] M. Parmar,et al. Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial , 2011, The Lancet.
[44] F. Grosse,et al. Human DHX9 helicase unwinds triple-helical DNA structures. , 2010, Biochemistry.
[45] Dimitris Thanos,et al. The transcriptional code of human IFN-beta gene expression. , 2010, Biochimica et biophysica acta.
[46] T. Hansen,et al. IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes. , 2009, Journal of molecular endocrinology.
[47] D. Thanos,et al. Virus Infection Induces NF-κB-Dependent Interchromosomal Associations Mediating Monoallelic IFN-β Gene Expression , 2008, Cell.
[48] S. Harrison,et al. An Atomic Model of the Interferon-β Enhanceosome , 2007, Cell.
[49] M. Bustin,et al. HMG chromosomal proteins in development and disease. , 2007, Trends in cell biology.
[50] Cheryl Bolinger,et al. RNA helicase A is necessary for translation of selected messenger RNAs , 2006, Nature Structural &Molecular Biology.
[51] W. Schmiegel,et al. CHEMORADIOTHERAPY FOR COLORECTAL CANCER , 2005, Gut.
[52] T. Okamoto,et al. RNA helicase A interacts with nuclear factor kappaB p65 and functions as a transcriptional coactivator. , 2004, European journal of biochemistry.
[53] Michael Thomas,et al. MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer , 2003, Oncogene.
[54] J. Terdiman,et al. Colorectal cancer screening: scientific review. , 2003, JAMA.
[55] M. Ohman,et al. Coordination of editing and splicing of glutamate receptor pre-mRNA. , 2003, RNA.
[56] Jeffrey D. Parvin,et al. RNA Helicase A Mediates Association of CBP with RNA Polymerase II , 1997, Cell.
[57] Mark Ellisman,et al. A cellular cofactor for the constitutive transport element of type D retrovirus. , 1997, Science.
[58] A. Simeone,et al. High level expression of the HMGI (Y) gene during embryonic development. , 1996, Oncogene.
[59] Dimitris Thanos,et al. Reversal of intrinsic DNA bends in the IFNβ gene enhancer by transcription factors and the architectural protein HMG I(Y) , 1995, Cell.
[60] T. Maniatis,et al. Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome , 1995, Cell.
[61] T. Maniatis,et al. The high mobility group protein HMG I(Y) can stimulate or inhibit DNA binding of distinct transcription factor ATF-2 isoforms. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[62] Dimitris Thanos,et al. The High Mobility Group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene , 1992, Cell.
[63] J. Henzen. Publisher's note , 1979, Brain Research.
[64] J. Thigpen. Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial , 2011 .
[65] A. Fusco,et al. HMGA and cancer. , 2010, Biochimica et biophysica acta.
[66] T. Maniatis,et al. The high mobility group protein HMG I(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene. , 1992, Cell.